XBiotech Inc (XBIT):企業の財務・戦略的SWOT分析

◆英語タイトル:XBiotech Inc (XBIT) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C14728
◆発行会社(調査会社):GlobalData
◆発行日:2019年3月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD300 ⇒換算¥41,400見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD600 ⇒換算¥82,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥124,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
XBiotech Inc (XBiotech) is a biopharmaceutical company that discovers, develops and commercialize therapeutic antibodies based proprietary technology. The company provides monoclonal antibodies treatment for various diseases. It’s lead product Xilonix, a therapeutic antibody being developed for the treatment of metastatic colorectal cancer. XBiotech offers clinical trial activity services, oncology, MRSA, and dermatology related solutions. The company develops a True Human technology to discover and develop targeted antibody candidates. It pipeline includes candidates, which target various therapeutic areas such as pyoderma gangrenosum, plaque psoriasis, influenza and Type II diabetes, among others. It has operations in the US, Switzerland, Japan and Germany. XBiotech is headquartered in Austin, Texas, the US.

XBiotech Inc Key Recent Developments

Dec 03,2018: XBiotech announces successful completion of GMP audit
Oct 31,2018: XBiotech highlights third quarter developments for 2018
Oct 26,2018: XBiotech Announces New Patents for Third Quarter 2018
Oct 05,2018: XBiotech Announces Enrollment Completion in Phase 2 Multicenter Study Evaluating Bermekimab in Patients with Atopic Dermatitis
Sep 26,2018: XBiotech Announces Granting of European Patent for Treatment of Inflammatory Skin Diseases

This comprehensive SWOT profile of XBiotech Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of XBiotech Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

XBiotech Inc – Key Information
XBiotech Inc – Overview
XBiotech Inc – Key Employees
XBiotech Inc – Key Employee Biographies
XBiotech Inc – Key Operational Heads
XBiotech Inc – Major Products and Services
XBiotech Inc – History
XBiotech Inc – Company Statement
XBiotech Inc – Locations And Subsidiaries
XBiotech Inc – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

XBiotech Inc – Business Description
XBiotech Inc – Corporate Strategy
XBiotech Inc – SWOT Analysis
SWOT Analysis – Overview
XBiotech Inc – Strengths
XBiotech Inc – Weaknesses
XBiotech Inc – Opportunities
XBiotech Inc – Threats
XBiotech Inc – Key Competitors

Section 3 – Company Financial Performance Charts

XBiotech Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

XBiotech Inc, Key Information
XBiotech Inc, Key Ratios
XBiotech Inc, Share Data
XBiotech Inc, Major Products and Services
XBiotech Inc, History
XBiotech Inc, Key Employees
XBiotech Inc, Key Employee Biographies
XBiotech Inc, Key Operational Heads
XBiotech Inc, Other Locations
XBiotech Inc, Subsidiaries
XBiotech Inc, Key Manufacturing facilities
XBiotech Inc, Key Competitors
XBiotech Inc, SWOT Analysis
XBiotech Inc, Ratios based on current share price
XBiotech Inc, Annual Ratios
XBiotech Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

XBiotech Inc, Performance Chart
XBiotech Inc, Ratio Charts

★海外企業調査レポート[XBiotech Inc (XBIT):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Biognosys AG-製薬・医療分野:企業M&A・提携分析
    Summary Biognosys AG (Biognosys) is a proteomics company that provides products and services for highly multiplexed protein quantification. The company offers products such as data independent acquisition data analysis software, smartest multiple reaction monitoring and parallel reaction monitoring …
  • Universal Hospital Services Inc:医療機器:M&Aディール及び事業提携情報
    Summary Universal Hospital Services Inc (UHS) is a clinical equipment service company that offers medical equipment management and service solutions. The company offers equipment services and equipment rental services. Its equipment services include clinical engineering, on-site management, surgical …
  • Grupo Aeroportuario del Sureste SAB de CV:戦略・SWOT・企業財務分析
    Grupo Aeroportuario del Sureste SAB de CV - Strategy, SWOT and Corporate Finance Report Summary Grupo Aeroportuario del Sureste SAB de CV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SW …
  • NYU Langone Medical Center:製薬・医療:M&Aディール及び事業提携情報
    Summary NYU Langone Medical Center (NYU LMC) a subsidiary of New York University School of Medicine is an academic healthcare center that provides patient care, education and research services. The center offers patient care services such as patient and family support; imaging services, medical serv …
  • CytomX Therapeutics Inc (CTMX):製薬・医療:M&Aディール及び事業提携情報
    Summary CytomX Therapeutics Inc (CytomX) is a clinical-stage biopharmaceutical company which develops novel therapeutic antibodies and Probody therapeutics for the treatment of cancer. The company’s leading product candidates include CX-072, CX-2009, BMS-986249, CX-2029, CX-188, probody drug conjuga …
  • Institute for Translational Vaccinology:製薬・医療:M&Aディール及び事業提携情報
    Summary Institute for Translational Vaccinology (Intravacc) is a nonprofit research and development organization that concentrates on the development of vaccines. The organization’s services include technology transfer, exploratory and clinical research and regulatory support. It also provides novel …
  • Ixia (XXIA):企業の財務・戦略的SWOT分析
    Summary Ixia (Ixia), a subsidiary of Keysight Technologies Inc, is a technology company that offers test architecture solutions and services. The company's products potfolio include visibility, test, cloud, security, performance monitoring, and test hardware products. Its security products comprise …
  • Lundin Mining Corporation:企業のM&A・事業提携・投資動向
    Lundin Mining Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Lundin Mining Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisi …
  • Cabot Corp (CBT):企業の財務・戦略的SWOT分析
    Cabot Corp (CBT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • MITIE Group Plc (MTO):企業の財務・戦略的SWOT分析
    MITIE Group Plc (MTO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Institut Pasteur-製薬・医療分野:企業M&A・提携分析
    Summary Institut Pasteur is a non-profit foundation that provides research, health services and education. The institute offers research in the areas of biology, genomes and genetics, immunology, infection and epidemiology, microbiology, neuroscience, parasitology and mycology, structural biology an …
  • Mitsubishi Logistics Corporation (9301):企業の財務・戦略的SWOT分析
    Mitsubishi Logistics Corporation (9301) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Domino’S Pizza Group Plc:企業の戦略・SWOT・財務分析
    Domino'S Pizza Group Plc - Strategy, SWOT and Corporate Finance Report Summary Domino'S Pizza Group Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Novolex Holdings, Inc.:企業の戦略的SWOT分析
    Novolex Holdings, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Austin Exploration Limited (AKK)-石油・ガス分野:企業M&A・提携分析
    Summary Austin Exploration Limited (Austin) is upstream oil and gas company that acquires, explores, develops, and produces oil and natural gas in the US. The company holds working interests in Colorado in the DJ Basin with the Niobrara and Pierre Shale as its primary oil and gas formations. It also …
  • University of Leicester-製薬・医療分野:企業M&A・提携分析
    Summary University of Leicester (UOL) is an educational service provider that offers undergraduate, postgraduate, distance learning and part-time programs. The university offers educational and research services in various disciplines such as mathematics, biochemistry, medicine, astrophysics, geneti …
  • Marks and Spencer Group plc:企業の戦略・SWOT・財務情報
    Marks and Spencer Group plc - Strategy, SWOT and Corporate Finance Report Summary Marks and Spencer Group plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Midmark Corp-医療機器分野:企業M&A・提携分析
    Summary Midmark Corp (Midmark) is a medical device company that manufactures and markets medical, dental and veterinary healthcare equipments. The company offers medical products such as power procedures tables and chairs, power examination tables, manual examination tables, lighting products, and i …
  • Oramed Pharmaceuticals Inc (ORMP):製薬・医療:M&Aディール及び事業提携情報
    Summary Oramed Pharmaceuticals Inc (Oramed) engages in the research and development of novel pharmaceutical solutions, comprising an oral insulin capsule for the treatment of individuals with diabetes, and orally ingestible capsules or pills for delivery of other polypeptides. It developed a unique …
  • Oceania Cruises, Inc.
    Oceania Cruises, Inc. - Strategy, SWOT and Corporate Finance Report Summary Oceania Cruises, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆